Related Experiment Video
Updated: Jul 30, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression
Bruce Culbertson1,2,3,4, Kristle Garcia1,2,3,4, Daniel Markett1,2,3,4
1Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.
Abstract:
Antisense RNAs are ubiquitous in human cells, yet their role is largely unexplored. Here we profiled antisense RNAs in the MDA-MB-231 breast cancer cell line and its highly lung metastatic derivative. We identified one antisense RNA that drives cancer progression by upregulating the redox enzyme NADPH quinone dehydrogenase 1 (NQO1), and named it NQO1-AS. Knockdown of either NQO1 or NQO1-AS reduced lung colonization in a mouse model, and investigation into the role of NQO1 indicated that it is broadly protective against oxidative damage and ferroptosis. Breast cancer cells in the lung are dependent on this pathway, and this dependence can be exploited therapeutically by inducing ferroptosis while inhibiting NQO1. Together, our findings establish a role for NQO1-AS in the progression of breast cancer by regulating its sense mRNA post-transcriptionally. Because breast cancer predominantly affects females, the disease models used in this study are of female origin and the results are primarily applicable to females.
Insights
A novel antisense RNA, NQO1-AS, drives breast cancer progression by upregulating NADPH quinone dehydrogenase 1 (NQO1). Inhibiting this pathway reduces lung metastasis and offers therapeutic potential for female breast cancer patients.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Antisense RNAs are abundant but their functions in human cells remain largely unknown.
- Understanding the roles of these RNAs is crucial for advancing cancer research.
Purpose of the Study:
- To profile antisense RNAs in breast cancer cell lines, specifically MDA-MB-231 and its lung metastatic derivative.
- To identify and characterize novel antisense RNAs involved in cancer progression and metastasis.
Main Methods:
- Profiling of antisense RNAs in distinct breast cancer cell lines.
- Gene knockdown experiments targeting NQO1 and the identified antisense RNA (NQO1-AS).
- In vivo mouse models to assess lung colonization and therapeutic interventions.
Main Results:
- Identification of NQO1-AS, an antisense RNA that upregulates NADPH quinone dehydrogenase 1 (NQO1), promoting cancer progression.
- Knockdown of NQO1 or NQO1-AS significantly reduced lung metastasis in a mouse model.
- NQO1 was found to protect breast cancer cells against oxidative damage and ferroptosis, a vulnerability exploitable therapeutically.
Conclusions:
- NQO1-AS plays a critical role in breast cancer progression by post-transcriptionally regulating its sense mRNA.
- Targeting the NQO1 pathway, by inducing ferroptosis and inhibiting NQO1, presents a potential therapeutic strategy for lung-metastatic breast cancer.
- The findings are primarily applicable to female breast cancer patients due to the use of female-origin disease models.
Related Concept Videos
MicroRNAs
The Nucleolus
lncRNA - Long Non-coding RNAs
Experimental RNAi
Translational Regulation
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

